Role of endothelium-derived relaxing factor in cerebral circulation: large arteries vs. microcirculation.
This study examined the hypothesis that formation of endothelium-derived relaxing factor (EDRF) in the brain has a greater influence on basal tone in large arteries than arterioles. Diameters of the basilar artery and its branches and of arterioles on the cerebrum were measured through cranial windows in anesthetized rats. Under control conditions, topical application of NG-monomethyl-L-arginine (L-NMMA), which inhibits formation of EDRF or nitric oxide (NO) from L-arginine, produced concentration-related constriction that was dependent on initial vessel diameter. Large arteries [diameter = 275 +/- 10 microns (mean +/- SE)] constricted by 10.4 +/- 0.8% in response to 10(-5) M L-NMMA. In contrast, arterioles (62 +/- 6 microns) constricted by only 3.7 +/- 0.6% (P less than 0.01 vs. large arteries), regardless of brain region. U-46619 produced similar constriction of large arteries and arterioles, which indicates that reduced responses to L-NMMA in arterioles is not due to impaired constrictor capacity. Sodium nitroprusside produced similar dilatation of large arteries and arterioles, which suggests that activity of guanylate cyclase is not reduced in small vessels. Dilator responses of large arteries and arterioles to acetylcholine, but not nitroprusside, were inhibited by L-NMMA. Thus synthesis of EDRF from L-arginine influences basal tone of cerebral blood vessels, and the effect is greatest in large arteries. In contrast, the role of EDRF or NO in mediating responses to acetylcholine in the cerebral circulation is similar in large arteries and the microcirculation.
Department of Internal Medicine, University of Iowa College of Medicine, Iowa City 52242.
F M
FM
Faraci
D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001120:Arginine / Q000031:analogs & derivatives / Q000494:pharmacology; D001158:Arteries / Q000187:drug effects / Q000502:physiology; D001160:Arterioles / Q000187:drug effects / Q000502:physiology; D002560:Cerebrovascular Circulation / Q000187:drug effects / Q000502:physiology*; D008297:Male; D009569:Nitric Oxide / Q000502:physiology*; D009599:Nitroprusside / Q000494:pharmacology; D011450:Prostaglandin Endoperoxides, Synthetic / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D019323:omega-N-Methylarginine
D011450:Prostaglandin Endoperoxides, Synthetic; D009599:Nitroprusside; D019323:omega-N-Methylarginine; D009569:Nitric Oxide; D019796:15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid; D001120:Arginine; D000109:Acetylcholine